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= Abstract = To study human colon cancer antigens, monoclonal antibodies were 
produced by immunizing balb/c mice with colon cancer cells(SNU-C1, originated 
from a Korean colon cancer patient). Among these monoclonal antibodies, one of 
IgM type antibody 7E02 was selected for further study. The 7E02 was prowd to be 
effective for immunohistological staining of colorectal cancer tissues. After 
purification by ammonium sulfate fiactionation and Sephacryl S-300 gel filtration, 
7E02 was labeled by 1-125. Using the radiolabeled 7E02, its dissociation constants 
(Kd) against SNU-C1 and SNU-C4 were measured by Scatchard plotting, and found 
to be 10.7 nM and 7.1 nM, respectively. When SNU-C1 was treated with 10 mM 
sodium periodate, 7E02 was not bound to the cell surface. However, SNU-C1 
preserved the activity to bind to 7E02 after N-acetyl neuraminidase treatment. With 
these results, we could conclude that the 7E02 binds to carbohydrate antigen that 
exists on the surface of colon cancer cell and excreted mucin. The antigen was 
proved not to contain terminal sialic acid. 
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INTRODUCTION 
Recently, immunoscintlgraphy using radlolabel- 
ed cancer-speclfic monoclonal antlbody has been 
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used extensively all over the world(K1m et a1 
1980, Chung et a1 1993) For the ~mrnunosclnt~g- 
raphy, development of monoclonal ant~body 
agalnst tumor antlgen I S  one of the most crltlcal 
step 
It has been known for a long tlme that cancer 
patlents have speclal materlal Increased In the~r 
body fluld These mater~als are called tumor mar- 
ker Some tumor markers are common mater~als 
those can be found In normal person such as 
hormones, enzymes, serum protelns and prote~n 
hydrolysates (Deland and Goldenberg 1985) How- 
ever, others are very uncommon In normal adult s 
body They are found ma~nly In tumor t~ssues or 
fetal tissues These materials are called oncofetal 
antigens Study of these oncofetal antigens be- 
came very act~ve after the detect~on of alfa-fet- 
oprotein (AFP Abelev et a / ,  1963) and carcinoem- 
bryonic antigen (CEA , Gold and Freedman 1965) 
D~stribution of colon cancer antigen CEA In tumor 
tissue has been studied extensively using quanti- 
tatlve autoradlography (Chung et a1 1994) 
Many k ~ n d  of oncofetal antigens exist on the 
surface of cancer cells Monoclonal antibodies 
against these antigens can be produced by Im- 
munizing animals with cancer cells One of the 
most famous colon cancer antigen which was 
proved by monoclonal antibody method is CAI 9- 
9 Monoclonal antibody against CA19-9 was prod- 
uced by lmmunlzlng balblc mlce w ~ t h  a colon can- 
er cell line SW1116 (Koprowski et a l ,  1978) Its 
molecular structure was proved to be sialylated 
Lewis a antigen by Magnani et a1 (1 981 1982) Its 
presence on the normal pancreatic epithelia and 
normal gastr~c membrane was proved by Immun- 
ohistological staining method (Atkinson et a1 , 
1982) Mucin type CA19-9 was detected in the 
sera of gastro~ntest~nal cancer patlents(Magnan1 
et a1 , 1983) 
In this experiment, we tried to produce mon- 
oclonal antibod~es against colon cancer cell line 
SNU-C1 which was derived from Korean male pat- 
lent, and studled some properties of produced 
monoclonal antibody and its ant~gen 
MATERIALS AND METHODS 
1. Cell Lines 
Human colon cancer cell lines, SNU-CI and 
SNU-C4 were used for immunization of balblc 
mlce and cell binding assay of monoclonal anti- 
body. Both of these cell lines were originated from 
Korean male colon cancer patients (Park et al. ,  
1984, 1985). 
Mouse myeloma cell line, P31U1 was used for 
making hybridoma cell line. This cell line was orig- 
inated from balblc myeloma and proved to be 
non-secretor of serum proteins. 
All the cells used in thls experiment were Incub- 
ated in RPM11640 medium containing 5 O/O fetal 
bovine serum and mainteined In 37°C incubator 
with 5 '10 CO2 enrichment. 
2. Reagents and Instruments 
The RPM11640 cell culture media and fetal bov- 
ine sera were purchased from Gibco company. 
Anti-mouse antibody goat antibody was from Sig- 
ma company. Sephadex G-50 and Sephacryl S- 
300 were purchased from Pharmacia company. I- 
125-Nal was obtained from DuPont NEN compan- 
y. Other reagents for buffer solutions were obtain- 
ed from Sigma or Wako company. Gamma scintil- 
lat~on counter (Multi-prias) was from Packard com- 
pany. COZ incubator (KMC-8409C) was manufac- 
tured by Korea Manhattan company. 
3. Preparation of Hybridoma 
Each balblc mouse was injected by l o 7  cul- 
tured SNIJ-C1 cells four sites on the back subcut- 
aneously. Booster injections were given 15 days 
and 20 days later by same number of cells intrap- 
eritoneally. Four days after the second booster 
dose, spleen cells were obtained from the immun- 
ized mouse and fused with P3lU1 myeloma cells 
(Kohler and Milstein 1975). The hybridoma were 
selected by hypoxanthine, aminopterine and 
thymidine enriched media. Monoclonal antibodies 
secreted in hybridoma supernatants were screen- 
ed by cultured SNU-C1 cells and 1-125 labeled sec- 
ond antibody (anti-mouse antibody goat anti- 
body). Eleven monoclonal antibodies those can 
bind to surface of SNU-C1 were selected by this 
method. These hybridoma were cloned by limited- 
dilution method using normal balblc mouse 
spleen cells for conditioning medium. The cloned 
hybridoma were harvested and stored in liquid ni- 
trogen after frozen in a medium composed of fet- 
al bovine serum : RPM11640 medium : dimethylsul- 
foxide = 50 : 40 : 10. 
4. Determination of Sub-lsotypes of Monoclonal 
Antibodies 
Anti-mouse immunoglobulins (IgG, IgA, and 
IgM) goat antibody (Sigma Co, 100~11, 0.05 mglml 
in 0.05 M sodium carbonate buffer, pH 9.5) was 
coated to 96-well ELlSA plate by incubating over- 
night at 4°C. Fifty pI of phosphate buffered saline 
(PBS) contalnlng 0 5 O/O Tween 20 and 50p1 of 
cloned hybr~doma supernatants were added to 
the ant~body-coated wells and Incubated for 1 
hour at room temperature After washlng w ~ t h  
PBS contalnlng 0 5  O/O Tween 20 three t~mes, 2 
drops of each blotln-conjugated antl-mouse IgG1, 
IgG2a, IgG2b, lgG3, IgA, and IgM solut~on (Amer- 
sham Co) were added and Incubated for 1 hour 
at room temperature After washlng wlth PBS con- 
talnlng 0 5 % Tween 20 three tlmes, 100!il of avld- 
~n-peroxldase conjugate solutlon (S~gma Co, dll- 
uted 1 500 In PBS) was added to each well and 
Incubated for 1 hour at room temperature After 
wash~ng wlth PBS contalnlng 0 5 %  Tween 20 
three t~mes, 50p1 of o-phenylened~amrne solutron 
contalnlng 0 1 '10 urea-hydrogen peroxlde was ad- 
ded and Incubated for 10 to 20 mlnutes In the 
dark Development of  orange color was stopped 
by addlng 50ji1 of 1 N hydrochloric acld 
5. lmmunostaining of Colon Cancer Tissues 
Thickness of 5pm sectlons on sllde glasses for 
mlcroscoplc ~nves t~ga t~on  were preparated from 
formalln-flxed paraffin-embeded colon cancer tls- 
sues The sectlons were hydrated by dlpplng In 
xylene, absolute ethanol, 90 '10 ethanol 70 O/O 
ethanol, 50% ethanol. and PBS, sequentially Pos- 
slble perox~dase actrvlty exlst~ng In the t~ssue prep- 
aratlon was destroyed by treatment In 0 3 %  hy- 
drogen peroxlde In ethanol, and washed by PBS 
agarn Hybrldoma supernatants were added on 
the top of the preparated tlssue-sect~ons, and 
Incubated overn~ght at 4°C In humrd chamber 
After washlng w~ th  PBS 3 tlmes, blotlnylated antl- 
mouse ~mmunoglobul~ns goat antlbody (diluted 1 
500 In PBS) was added and Incubated for 1 hour 
at room temperature After washlng w ~ t h  PBS 3 
tlmes, avldln-perox~dase (d~luted 1 200 In PBS) 
was added and Incubated for 1 hour at room tem- 
perature After washlng wlth PBS 3 tlmes. AEC sol- 
u t~on  contarn~ng 0 190 urea-hydrogen peroxrde 
was added and Incubated for 15-25 mlnues at 
room temperature Excess~ve development of col- 
or was stopped by washrng In tab water The Im- 
munostalned sample was stalned agaln wlth hem- 
atoxllln 
6. Purification and 1-125 Labeling of Monoclonal 
Antibody 
Cultured hybr~doma ( I  0' cells) were injected 
Into the perltonia of prlstane-primed balblc mice, 
and ascltic fluids were obtained from the balblc 
mrce about 1 week later. Monoclonal antlbody 
was purified from the pooled ascltic fluld by pre- 
clpltatlon with 50% saturation of ammonium sul- 
fate tw~ce and successive gel-filtration with Sep- 
hacryl S-300 column chromatography ( l . 5cm X 
100cm). The purity of monoclonal antibody was 
confirmed by SDS-PAGE. To study binding con- 
stants, the purlfied monoclonal antibody was rad- 
iolabeled by 1-1 25 (Hunter and Greenwood 1962). 
7. Scatchard Plotting of Monoclonal Antibody 
Cultured colon cancer cell line SNU-CI (1.8 X 
105 cells) or SNU-C4 (2.0 X I O5 cells) were incub- 
ated wrth ser~ally diluted 1-125 labeled monoclonal 
antibody for 1 hour at room temperature. The cell 
bound radloactlvlty was measured by gamma 
sc~nt~ l la t~on counter after washing the incubated 
cells wlth PBS. Affinlty constants were determined 
by Scatchard plotting. 
8. Treatment of SNU-C1 with Neuraminidase and 
Per iodate 
To study the chemlcal properties of the cell sur- 
face antlgen, SNU-C1 was treated w ~ t h  neuramln- 
ldase(1 Unlt, 1 hour at 37°C) or periodate (20 mM, 
1 hour at 37°C) and tested for the binding of mon 
oclonal antibody (Coligan and Todd 1975). 
RESULTS 
lmmun~zat~on of balblc mlce was performed by 
subcutaneous lnjectlon of SNU-C1 cells and sub- 
sequent booster lnjectlon Into peritoneum Harves 
tlng SNU-C1 cells from cultured medla was slm- 
ple, because the cells were not bound to the sur- 
face of culture bottle However, to harvest SNU- 
C4 that grows bound to the surface of culture bot- 
tle trypsln~zatlon was necessary Spleen cells of 
the ~mmunlzed mlce and a mouse myeloma (P3U1) 
were fused by PEG method The ratlo between 
Mlcroscop~c views of human colon cancer 
tlssues ~mmunoh~stolog~cal ly sta~ned by 
7E02 Each formal~n-f~xed tlssue was treated 
In tap water overnight to e l~m~nate formalln 
Blocks were made wlth these tlssues by 
embedding In paraffln, sect~oned to 5pm sec- 
tlons by mlcrotome, and the sect~ons were 
loaded onto sllde glasses The paraffln was 
ellmlnated by dlpplng In xylene 3 tlmes for 5 
mlnutes each The tlssue-bound sllde glas- 
ses were 'reated by absolute ethanol, etha- 
nol cont alnlng 0 3 '10 hydrogen peroxlde (de- 
stroy endogeneous perox~dase), 90 '10 
ethanol 70'0 ethanol. 50% ethanol, snd PBS sequentlally for 10 mlnutes each The 7E02 was ap- 
plhed to the treated sample and Incubated for 1 hr at room temperature In humld chamber, and 
the sllde glasses were washed by PBS 3 tlmes for 10 mlnutes each Blotln-labeled anti-mouse goat 
antlbody and avldln-peroxldase conjugate were mounted as the same way sequentlally AEC sol- 
utlon contalnlng 0 1 '10 urea-hydrogen perox~de was applled to the treated sample and Incubated 
for 15 to 25 mlnutes and the sllde glasses were washed by PBS tw~ce for 10 mlnutes each After 
counter-stalnlng wlth hematoxllln photographs were taken under a microscope 
Each formalln-flxed tlssue IS a well dlfferentlated adenocarc~noma, b muclnuous carclnoma, c, 
normal colon tlssue 
spleen cell and myeloma to achleve best hybrld- 
lzatlon yleld was found to be about 8 1 
The fused cells were dispensed Into 192 wells 
and 151 wells showed growth of hybrldoma 
Among the 151 hybrldoma 1 1  of them showed 
SNU-C1 blndlng actlvlty Only 3 o f  them showed 
app l~cab~ l~ ty  for lmmunostalnlng Among the 3 
monoclonal antibodies one (7E02) was selected 
and studled further The 7E02 was proved to be 
IgM by the method decrrbed above 
lmmunoh~stogram shows that 7E02 blnds to 
well dlfferentlated colon cancer tlssue heterog- 
eneously (Fig 1 a) It b~nds  mucln as well as cell 
surface In muclnous carclnoma (Fig 1 b) ,  how- 
ever, does not blnd to nomal colon tlssue (Fig 
1c)  Antl-CEA antlbody also blnds to both muclne 
and cell surface 
The dlssoclat~on constant (Kd) of 7E02 to S N U -  
Bound (mg/d)  
Bound (mg/ml) 
Fig. 2. Scatchard plotting of 7E02 binding t o :a ,  
SNU-C1 cells; b, SNU-C4 cells. Ratio of 
bound to free 1-125 labeled 7E02 plotted 
against amount of bound 1-125 labeled 
7E02 expressed as mglml of 7E02. The Kd 
value and the maximum binding capacity 
were determined by slope and x-intercept, 
respectively. 
C1 and SNU-C4 were 10.7 nM and 7.1 nM, re- 
spectively(Fig. 2). These results shows moderate 
affinity of monoclonal antibody to the colon can- 
cer cells. Number of epitopes on the surface of 
SNU-C1 and SNU-C4 were calculated as 3.3 x 1 O6 
/cell and 1.3 x 105/cell, respectively (Fig. 2). 
After treatment of SNU-C1 with N-acetyl neur- 
aminidase at 37°C for 1 hour, no alteration in the 
binding activity of 7E02 to SNU-C1 was observed 
(Fig. 3). However, treatment with sodium per- 
iodate destroyed the binding activity of 7E02 to 
Fig. 3. Blndlng of 7E02 to SNU-C1 cells treated 
wlth neuramlnldase or sodlum perlodate 
SNU-C1 cells (3 x 1 05) were treated wtt h 1 
U neuramlnldase or 10 mM sodlum per- 
Iodate for 1 hour at 37°C In the dark, was- 
hed with 2 rnl of PBS, ~ncubated wlth 400jil 
of 1-1 25 labeled 7E03 (1 1,600 cpm) for 1 hr 
at room temperature, centr~fuged at 3,000 
rpm, and counted the rad~oactlvltles of the 
preclpltated cells wlth sc~nt~ l la t~on counter 
Non-spectf~cally bound radloactlvlty 1, was 
measured by countlng non-treated cells 
Incubated wlth 1 mgI400pl of non-labeled 
7E02 and 1-1 25 labeled 7E02 (1 1,600 cpm) 
Method to determine total bound actlvlty 
2, was the same as that of non-speclflcally 
bound actlvlty except the absence of 
non-labeled 7E02 Cells are treated by 3, 
neuramlnldase, 4, sodlum perlodate 
SNU-C1. These results show that the antlgen IS 
composed of carbohydrate that does not contaln 
termlnal N-acetyl neuramlnlc acld 
DISCUSSION 
There are normal antlgens as well as cancer 
antlgens on the surface of cancer cells Hybrtd- 
oma technology IS one of  the best method to ~den-  
tlfy cancer antlgens exlstlng on the surface of 
cancer cells A lot of hybrldoma whlch produce 
monoclonal anttbodles agalnst normal antlgens 
or non-speclflc ant~gens can be ellmlnated by sel- 
ectlng adequate screening method We used co- 
lon cancer cells whlch was used for lmmunlzlng 
the balblc mtce and colon cancer tlssues to 
screen the speclflc~ty of produced monoclonal 
antlbodles In thls experiment 
~ l ~ c o p r o t e ~ n  or g lyco l~p~d IS the most common 
chemlcal nature of cancer antlgens Two most 
famous glycoproteln cancer antlgens are alfa-fet- 
oproteln and CEA Alfa-fetoprote~n exlsts hlgh con- 
centrat~on In the sera of fetus and hepatoma pat- 
lents CEA IS found In human gastro~ntestlnal 
adenocarclnoma or fetal gastrolntestlnal tlssue 
wlth molecular welght 180,000 dalton (Gold and 
Freedman 1965) Bast et a/, produced monoclon- 
al ant~body OC125 and OC133 agalnst ovarlan 
cancer (1  981 ) The OC125 and OC133 were prov- 
ed to be glycoproteln wlth molecular welght > 
200,000 and 80 000 dalton, respectively (Masuho 
et a/. 1984) A melanoma antlgen p97 whlch has 
sequence homology wlth transferrln or lactotran- 
sferrln was proved to be a glycoproteln wlth mol- 
ecular welght 97000 dalton (Brown et a/. 1982) 
Accord~ng to thelr hlgh molecular welght and 
complex~c~ty, glycoproteln ant~gens are more dlffl- 
cult to study the chemlcal nature than g lyco l~p~d 
antlgens 
On the other hand glycol~p~ds ant~gens are eas- 
ler to analyze and studled more systematically 
than glycoproteln antlgens Malnly, three klnds of 
changes were found In glycollpld when normal 
cells transformed to cancer cells I )  accumulat~on 
of rare glycol~p~ds due to blockade of blosynthes- 
I S  of certatn glycollp~d 1 1 )  synthesis of new glycol- 
~ p ~ d  according to the actlvatlon of normally Inac- 
tlve glycosyl transferase, and i i i )  revealed glycol- 
~p ld ,  which has been hidden by other antigens in 
normal cells, due to physicochemical changes in 
cell membrane (Hakomorl 1984, 1985). 
I f  anlmals are immunized by cancer cells, then 
the resulting ant~bodles will be produced against 
carbohydrate side chain of glycoproteins or 
glycol~p~ds. According to our results, epitope of 
7E02 antlgen IS proved to be carbohydrate exist- 
Ing both on the cell surface of colon cancer and 
mucus of mucinuous carcinoma. However, it is 
not proved whether the antigen is glycoprotein or 
glycollp~d. 
In conclus~on, we could successfully produce 
monoclonal antibody against colon cancer cell 
(SNU-C4), and the antibody specifically binds to 
carbohydrate epitope whlch exists colon cancer 
tlssues and mucin. 
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